Connection

Sui-Yuan Chang to Protease Inhibitors

Back to Details
This is a "connection" page, showing publications Sui-Yuan Chang has written about Protease Inhibitors.
Sui-Yuan Chang
Connection Strength
0.215
Protease Inhibitors
  1. Kinetic Characterization and Inhibitor Screening for the Proteases Leading to Identification of Drugs against SARS-CoV-2. Antimicrob Agents Chemother. 2021 03 18; 65(4).
    View in: PubMed
    Score: 0.070
  2. Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects. Cell Rep. 2020 10 13; 33(2):108254.
    View in: PubMed
    Score: 0.067
  3. Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients. Int J Antimicrob Agents. 2019 Jul; 54(1):35-42.
    View in: PubMed
    Score: 0.061
  4. Uncovering Flexible Active Site Conformations of SARS-CoV-2 3CL Proteases through Protease Pharmacophore Clusters and COVID-19 Drug Repurposing. ACS Nano. 2021 01 26; 15(1):857-872.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.